欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/2626/006
药品名称Sitagliptin/Dapagliflozin Egis
活性成分
    • Dapagliflozin 10.0 mg
    • Sitagliptin 100.0 mg
剂型Film-coated tablet
上市许可持有人Egis Pharmaceuticals PLC Hungary
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Lithuania (LT)
    • Hungary (HU)
    • Czech Republic (CZ)
      Sitagliptin/Dapagliflozin Egis
    • Slovak Republic (SK)
    • Poland (PL)
      Sitagliptin + Dapagliflozin Egis
    • Latvia (LV)
许可日期2025/11/19
最近更新日期2025/11/20
药物ATC编码
    • A10BD29 sitagliptin and dapagliflozin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Fixed Combination
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase